|
|
||||||||
1 Division of Perinatal Medicine, Department of Reproductive Medicine, University of California, San Diego, La Jolla, California 92093-0802; 2 Department of Pediatrics, University of Arkansas for Medical Sciences and 3 Arkansas Children's Hospital Research Institute, Little Rock, Arkansas 72202-3591
| |
ABSTRACT |
|---|
|
|
|---|
Red cell life span within the fetal circulation has not been reported, although erythrocyte life span has been studied in the adult and newborn. The present study quantified red cell life span in 12 chronically catheterized fetal sheep at 97-136 days gestation (term = 150 days) with the use of autologous red cells labeled with [14C]cyanate. Cyanate forms a permanent covalent bond with hemoglobin and acts as a permanent red cell label. In the fetuses, blood 14C activity decreased in a curvilinear fashion with time and reached 50% of the initial activity at 16.4 ± 1.6 (SE) days. In contrast, 14C activity of autologous red cells in two adult ewes decreased linearly with time as expected, reached 50% of the initial 14C activity in 59 days, and yielded life spans of 117 and 121 days. Computer modeling and parameter optimization taking into account growth and skewed life span distribution were used to analyze the 14C disappearance curve in each fetus. The mean life span of all red cells in the fetal circulation was 63.6 ± 5.8 days. Mean red cell life span increased linearly from 35 to 107 days as fetal age increased from 97 to 136 days (r = 0.83, P < 0.001). Life span of cells produced at the time of labeling was significantly greater than the mean life span. Fetal growth rate estimated from parameter optimization was 3.28 ± 0.72%/day; this compared well with the rate of 3.40 ± 0.14%/day calculated from fetal weights at autopsy. Mean corpuscular volume decreased as a function of gestational age, but the decrease was small compared with the large increase in red cell life span. We conclude the following: 1) red cell life span in the fetal circulation is short compared with the adult; 2) red cells in younger fetuses have shorter life spans than in near-term fetuses; 3) the curvilinear disappearance of labeled red cells in the fetus appears to be due primarily to an expanding blood volume with fetal growth; and 4) red blood cell life span in a growing organism will be significantly underestimated unless the expansion of blood volume with growth is taken into account.
growth; mean corpuscular volume
| |
INTRODUCTION |
|---|
|
|
|---|
IN MAMMALS, MANY MILLIONS of newly produced red blood cells are released into the circulation each day as older red cells are lost or removed from the bloodstream. The average time that an erythrocyte remains in the circulation is termed the red cell life span. Because red cell life span is a potentially important determinant of oxygen delivery to the body's tissues, the theoretical basis for determining red cell life span has been well validated in adults, and methods based on theory have been applied frequently to measurements in animals including humans (7, 13, 15). The random labeling method is the most commonly used technique for determining red cell life span; typically, an aliquot of autologous or homologous red blood cells is radiolabeled and infused into the circulation. The disappearance of the labeled cells from the circulation is measured as a function of time, and the resulting disappearance curve is interpreted in terms of life span by performing a straight line extrapolation to the time when no labeled cells remain in the circulation (13). The same method of life span determination has been used when red cells with compatible yet unique surface antigens rather than cells labeled with radioisotopes were injected (17).
Mammalian red cell life span is ~120 days in adults of different species, including humans and sheep (7, 13, 15, 20). The life span of fetal red cells within the fetal circulation has not been previously reported. Furthermore, methods for accurately interpreting disappearance curves of labeled red cells in rapidly growing organisms such as fetuses have not been published. Past studies have attempted to estimate red blood cell life span in the fetus by studying either the newborn or "fetal" red cells isolated from the umbilical cords and/or placentas at the time of delivery. These studies have generally suggested that red cell life span in the fetus and newborn is shorter than in the adult (6, 10, 11). However, most of the previous studies used interpretation methods for the adult and hence do not provide an accurate estimate of fetal erythrocyte life span for several reasons including the following: 1) dilution of the label due to the rapid expansion of blood volume with growth generally was not taken into account (17); 2) variable elution of the radiolabel from the red cells occurred, and this can be especially large in the fetus (9, 20); and 3) the skewed distribution of the life span of cells in the fetal circulation was not considered (6). Furthermore, preferential removal of the fetal cells from the newborn or adult circulation may have occurred because fetal cells are larger and express different surface antigens. Preferential removal has been reported in both humans (9) and sheep (20) even after matching of blood types. Most of these factors would cause the disappearance curve in the fetus to be curvilinear rather than linear. Furthermore, when using the straight line extrapolation method that works well in the adult, each of the above factors would cause the estimated red blood cell life span to underestimate the true life span in the fetus and newborn. Another complicating factor is that some studies have found fetal red cell life span to be the same as in the adult (8, 11). There presently exists no explanation for this discrepancy with studies suggesting that fetal red cells have a short life span.
The purposes of the present study were threefold: 1) to develop a quantitative method that can be used to accurately determine red blood cell life span from disappearance curves in growing organisms; 2) to determine erythrocyte life span in the ovine fetus as a function of gestational age; and 3) to use both the new method and the observed fetal red blood cell life span values to interpret potential errors and discrepancies in previously reported fetal erythrocyte life spans.
We used three techniques to determine red cell life span in the fetus while avoiding the problems of past studies. First, the chronically catheterized fetal sheep was used as an animal model so that the life span of autologous cells could be determined directly within the fetal circulation. Second, 14C-labeled cyanate was used as a red cell label; the permanent covalent bond between cyanate and hemoglobin renders loss of the label due to elution negligible (12, 13, 16). Third, computer-modeling and parameter-optimization techniques that take into account fetal growth and changes in the red cell life span during gestation were used to analyze the curvilinear disappearance of the labeled fetal cells, yielding precise estimates of red cell life span as a function of fetal age and an independent, verifiable estimate of fetal growth rate.
| |
METHODS |
|---|
|
|
|---|
Animal studies. Twelve chronically catheterized fetal sheep and two nonpregnant adult ewes were studied. The protocol was approved by the Animal Subjects Committee of the University of California, San Diego. The National Research Council's Guide for the Care and Use of Laboratory Animals was followed.
Each of the 12 pregnant ewes carried a single fetus. Gestational age at the time of surgical catheter implantation ranged from 92 to 131 days (term = 145-150 days). The surgical preparation, animal care, and maintenance have been described in detail elsewhere (3, 4). Briefly, under inhalation anesthesia with the use of aseptic techniques, polyvinyl catheters were placed in fetal and maternal femoral arteries as well as attached to the fetal skin for accessing the amniotic fluid. In fetuses with a gestational age <100 days at the time of surgery, a vascular catheter was placed in a fetal carotid artery rather than a femoral artery. The catheters were passed subcutaneously into a pouch sewn to the flank of the ewe. Prophylactic antibiotics were administered at the time of surgery to the ewe and over the first 5 postsurgical days to the fetus (4). Experiments began on postoperative day 5. Plasma was removed and saved from 1 ml of fetal blood, the red cells were washed three times to remove white cells and platelets, and the red cells were labeled with [14C]cyanate by incubation for 30 min as previously described (14, 16). The labeled cells were washed four times to remove unbound [14C]cyanate and resuspended in the saved plasma before injection into the fetal circulation (14, 16). Fetal arterial blood was sampled at 1-h postinjection and at 24-, 48-, or 72-h intervals thereafter for a maximum of 26 days at fetal gestational ages ranging from 97 to 150 days. Sample volume (0.25 ml in fetuses <112 days gestation at the start of the study and 0.5 ml in fetuses
112 days) was chosen to minimize the amount of blood and
radioactivity removed (<2% of that injected). On the basis of studies
in newborn sheep in which fetal hemoglobin was present in high
concentrations at birth and disappeared completely from the circulation
within 2-3 wk after birth (1, 21), a short red cell
life span was anticipated. Thus initial studies were designed to sample
for only 14 days. However, preliminary analyses of samples from the
first six animals revealed that [14C]cyanate-labeled red
cells remained in the fetal circulation at 2-wk postinjection. Thus the
sampling period was extended until catheter failure or delivery to
better characterize red cell disappearance.
To compare fetal with adult values measured by the same technique in
the same laboratory, two nonpregnant adult ewes aged 2-3 years
were studied. The femoral artery was catheterized chronically; red
cells from 2 ml of blood were removed and labeled with
[14C]cyanate, washed four times, and reinfused. Blood
samples (1 ml) were taken at 1-h postinjection, three times weekly for
the first month, and weekly thereafter for 101 days.
From each 0.5-ml fetal blood sample, 0.05 ml were used for
determination of hematocrit in triplicate (3), and 0.2 ml
were used for determination of blood gases and pH (Nova Stat Profile Ultra analyzer). The remaining 0.25 ml of blood were divided into two
equal aliquots, weighed, and stored for 14C counting. For
the 0.25-ml blood samples from the younger fetuses, hematocrit and
blood gases were not determined to minimize the effect of sampling on
blood and 14C loss from the fetus. Plasma protein
concentration was determined refractometrically from the plasma in the
hematocrit tubes (3). For the two adult sheep, hematocrit
was determined in triplicate, and the remaining blood was weighed and
stored in two aliquots. Stored samples were anticoagulated with heparin
and refrigerated until analyzed.
Mean corpuscular volume (MCV) (i.e., the average volume per red cell)
was determined in four fetuses from this study and in 23 fetuses in
other concurrent studies with the use of a Coulter Multisizer model
IIe. Calibration of the Multisizer was performed with the use of human
red cell standards (4 C tri pack; Coulter, Miami, FL).
From the stored blood samples, hemoglobin with the bound
14C was isolated with the use of an acid-acetone-water
extraction procedure as detailed elsewhere (14, 16). The
protein precipitate was dissolved in liquid scintillation counting
fluid (Ecolume; ICN Biomedicals, Irvine, CA) and counted for 10 min per
sample. The radioactivity per gram of blood was normalized with respect
to time with the day 0 value taken as 100%.
In the fetus, the circulating red cell label is diluted over time as
blood volume expands with growth. As an independent measure of growth,
body weights were measured at autopsy in 46 fetuses over the age range
of 100-147 days gestation, and average growth rates were calculated.
Life span determination. In the adult, the method of determining red cell life span from disappearance curves is well established and is straight forward (13). In the fetus, the method for interpreting disappearance curves has not been established, and there are a number of complicating factors. These factors are typically assumed constant in the adult but had to be taken into account in development of the method for determining red cell life span in the fetus: 1) an increasing absolute rate of red cell production; 2) increasing life spans of newly produced red blood cells as the fetus ages; and 3) somatic growth that leads to increases in blood volume with time. To illustrate development of the method for determining red cell life span in the fetus, the following description compares the effects of these factors in the adult and fetus.
Each day, the adult releases a large number of new erythrocytes into the circulation. Figure 1A illustrates the distribution of life spans of the cells released on a given day assuming the newly released cells have a life span of 120 ± 2 (SD) days. At steady state, the adult continues to release the same number of new erythrocytes each day as the previous day, and the distribution of life spans is the same (Fig. 1A). Each day, the oldest erythrocytes are removed from the circulation due to senescence, and the cells remaining in circulation have 1 day less remaining in their lives. Hence, the distribution of the remaining life of all red cells in the circulation is flat as illustrated in Fig. 1B, with a drop to zero cells for any time greater than the mean life span (plus ~2 SD) of the newly released cells. To determine life span in the adult with the use of the random labeling method, a sample of blood is labeled and injected into the circulation. Because the remaining life distribution is flat, the disappearance of these labeled cells from the circulation declines linearly with time (Fig. 1C). Due to spread in life span distribution of the newly released erythrocytes, the disappearance curve deviates slightly from linear near the intersection of the linear portion and the time axis. Red cell life span is then determined analytically by using least-squares linear regression to define the point at which the regression line intersects the time axis. The shape of the distribution of the life span of the newly released cells (Fig. 1A) affects the disappearance curve only near the intersection with the time axis and thus typically has no effect on the calculated life span because disappearance curves typically are followed for only 50-80% of the life span.
|
|
Data presentation and statistical analysis.
Experimental values are presented as the mean ± 1 SE. The two
values of fetal blood 14C activity for each day were
averaged before analysis. Bivariate and multivariate correlation and
least-squares regression were used to determine relationships between
optimized parameter values and fetal gestational age. A lower case
r represents bivariate and upper case R
represents multivariate correlation coefficients. 14C
disappearance curves were considered curvilinear if second or higher
order terms from polynomial regression were statistically significant.
Hematocrit changes with time in the two adult ewes were analyzed with a
two-factor repeated-measures ANOVA. Fetal weights at autopsy were log
transformed to linearize before regression analysis. A paired
t-test was used to determine the statistical significance of
the difference between mean life span for all cells in the circulation
and the life span of newly released cells as well as the difference
between the mean life span and the life span as determined by linear
extrapolation. Changes in MCV with gestational age were analyzed with
polynomial regression. For all tests, statistical significance was
chosen as P
0.05.
| |
RESULTS |
|---|
|
|
|---|
In the 12 fetuses, red cell labeling occurred at 118.1 ± 3.5 (SE) days gestation; range = 97-136 days. The 14C
label disappeared from the fetal circulation in a curvilinear fashion
(P < 0.01) and reached 50% of the day 0 value at an average of 16.4 ± 1.6 days (Fig.
3).
|
Red cell life span as determined from computer modeling and parameter
optimization for mean data is illustrated in Fig.
4 and is compared with the linear
extrapolation method as used in the adult. For the 12 fetuses, the mean
correlation coefficient between experimental values and the simulated
disappearance curve was 0.946 ± 0.010. The average life span for
all red cells in the fetal circulation was 63.6 ± 5.8 days
(range = 29.6-95.8 days). This is 5.5 ± 1.4 days
shorter (P = 0.0028) than the life span of red cells
released at the time of labeling (69.1 ± 6.3 days; range
34.6-104.8 days). Using the straight line extrapolation method as
used in the adult yielded a life span of 36.5 ± 4.7 days, a value
significantly less than the mean life span (P < 0.0001).
|
Both the life span of all red cells in the circulation and the life
span of newly released red cells exhibited a significant positive
relationship with fetal gestational age (Fig.
5). The slopes of the two regression
equations were 1.37 ± 0.30 and 1.54 ± 0.03 days/day,
respectively. These slopes both differ significantly from zero
(P < 0.001) but are not significantly different from each other (P = 0.58). Extrapolation from the
regression equations to term (150 days) yields a life span for all red
cells of 107.4 ± 3.8 days compared with 118.3 ± 3.9 days
for the newly released cells. This difference approached statistical
significance (P = 0.058).
|
From the optimized parameter values, the daily increase in life span with advancing gestation in the 12 fetuses was 0.52 ± 0.22 days/day. From regression analysis, this parameter was not significantly related to gestational age.
Mean values for fetal hematocrit, plasma protein concentration,
arterial pH, and blood gas values over the gestational age range of
112-150 days are listed in Table 1.
Hematocrit, plasma protein concentration, and arterial carbon dioxide
tension correlated positively and significantly with gestational age,
whereas oxygen tension and pH were not correlated significantly with
age (Table 1).
|
From measured fetal weights at autopsy, there was an exponential
increase in fetal weight as a function of gestational age (Fig.
6). The regression equation was best
described as a power function (weight = 35.421 × 1.034Age) where weight is in grams and gestational age is
in days. This corresponds to a growth rate of 3.40 ± 0.14%/day.
Fetal growth rate as determined from the disappearance curves with the
use of parameter optimization was 3.28 ± 0.72%/day. These values
do not differ statistically (P = 0.79). Furthermore,
fetal growth rate as determined from modeling was not significantly
related to gestational age.
|
MCV (red cell) in the fetuses decreased with increasing gestational age
(Fig. 7); the polynomial regression
relationship is MCV = 99.4
0.8345 × Age + 0.0028 × Age2. The most rapid age-related decrease
occurred in the midgestation fetuses; by contrast, MCV decreased only 7 fl (from ~45 fl to 38 fl) over the age range for which red cell life
spans were determined. With the use of MCV calculated from the
regression equation, there was a negative correlation between red cell
life span and MCV (r =
0.595, P = 0.042). With the use of multivariate regression, both gestational age
and MCV were significantly related to red cell life span
(R = 0.892, P < 0.00001).
|
The disappearance curves and red cell life span determinations for the
two adult sheep that were studied are shown in Fig. 8. Both disappearance curves were linear
with time. Blood 14C concentration was reduced to 50% of
its initial value at 59 days. Average red cell life span was 119 days.
Hematocrit did not change significantly with time in these animals
(P = 0.51).
|
| |
DISCUSSION |
|---|
|
|
|---|
The present study was designed to determine the life span of red blood cells in the circulation of the ovine fetus from labeled red cell disappearance curves. On the basis of our findings, we conclude the following: 1) Red cell life span in the ovine fetus is less than that in the adult; 2) Fetal red cell life span increases with gestational age; 3) The mean life span of all erythrocytes in the fetal circulation is less than the life span of the newly released red cells; 4) Methods used in the adult for interpreting disappearance curves significantly underestimate red cell life span in the growing fetus; and 5) To appropriately interpret curvilinear fetal disappearance curves, a computer model with parameter optimization was necessary so that the expansion of fetal blood volume with growth, increases in life span with gestational age, and a skewed life span distribution could be taken into account simultaneously.
The conclusion that fetal red cell life span is less than that in the adult is on the basis of the present observation that erythrocyte life span in the ovine fetus during the last third of gestation averaged 64 days, which is about half of the adult values that averaged 119 days. Although we studied only two adult sheep, their values agreed well with a much larger body of data indicating that erythrocyte life span in adult sheep is ~120 days (14, 20). Other investigators have concluded that fetal red cell life span is less than adult red cell life span, so it may be questioned what is new about our study. However, none of the previous studies examined red cell survival in the fetal circulation. Furthermore, the previous studies generally used interpretation methods that were theoretically unsound because the effects of growth were not taken into account (6, 7, 9, 10, 17, 20). The current study significantly improves the quality of the knowledge base underlying the conclusions that erythrocyte life span in the fetal circulation is short and that it increases with gestational age because the methodology used allowed proper interpretation of the disappearance curves in terms of both fetal growth and the changing distribution of red cell life span with gestational age. Both of these factors can have large effects on the shape of the disappearance curve and hence on the estimated life span. For example, with application of the commonly used straight line interpretation method to the disappearance curves from the present study, mean fetal red cell life span would be underestimated by almost 50%.
It might be suggested that even though the fetal disappearance curves were slightly curvilinear, they are sufficiently close to linear so that the straight line interpretation as used in the adult is appropriate. However, linear interpretation is on the basis of the assumption that no growth is occurring so that blood volume is constant, and it is also on the basis of the assumption that all red cells have the same life span when released into the circulations. Neither of these assumptions is valid in the fetus. Thus not only is the basis of the straight line method not applicable to the fetus, but the logical flow is strikingly emphasized by the underestimation of the life span in the growing organism.
The curvilinear nature of the disappearance curves found in the present study has been observed in previous studies in young and growing animals and humans. However, past studies have interpreted such data as indicating either that there exists two populations of red cells with some having a short life span or that some cells were damaged during the labeling process and thus were disappearing from the circulation more quickly than normal (6, 14). Although the latter remains a possibility for some labeling methods, the present study suggests that the primary cause of the curvilinear nature of the disappearance curve in the growing animal is the dilution of labeled red cells due to expansion of blood volume with growth. In fact, the estimate of fetal growth rate in the present study agreed so well with the growth rate determined from measured body weights that the curvilinearity can be almost attributed entirely to growth because the increase in life span with gestational age had only a small effect as illustrated in Fig. 2. This conclusion is on the basis of the assumption that ovine fetal blood volume expands at the same rate as body weight. Two observations support this assumption: 1) blood volume in the chronically catheterized ovine fetus expands at a rate of 3.5 ± 0.5%/day (19), a value essentially the same as the 3.28 ± 0.72%/day determined from computer modeling and 3.40 ± 0.14%/day calculated from fetal weights at autopsy in the present study; and 2) weight-normalized blood volume in the chronically catheterized ovine fetus is independent of fetal body weight over a wide range of fetal weights (3).
The present study also detected a significant increase in fetal red cell life span with gestational age. This results in a mean life span of all red cells in the fetal circulation that is significantly less than the life span of the newly released red cells. This difference aids in evaluating conflicting results of previous studies. For example, although most previous studies have concluded that the life span of fetal red cells is shorter than that of the adult, a few studies have concluded that fetal and adult red cell life spans are the same (8, 11). The latter studies used the tracer incorporation method that labels the newly produced red cells, whereas the other studies used the random labeling method that labels all red cells in the circulation. Although these two methods will yield the same estimate of life span in an organism such as the adult, which has a constant vascular volume and erythrocyte life span, they will yield different life spans in growing organisms and in organisms with changing red cell life spans. This difference can be of particular importance when studying red cells in newborns at the time of birth because, as seen from the present study by extrapolation of the fetal regression equations, estimated red cell life span of the newly produced red cells at term was 118 days or the same as adult values, whereas the mean fetal red cell life span was less than adult values. Furthermore, the tracer incorporation methods as used are more likely to produce an accurate estimate of life span because they included correction for blood volume expansion with growth. This calls into question previous studies that suggest that red cell life span in the newborn is less than that in the adult for two reasons. First, with extrapolation of the regression equation to term, life span of the newly released fetal red cells was the same as life span in the adult. Second, red cell life span without correction for fetal growth as determined by the random labeling method will significantly underestimate true life span.
This study of red cells circulating in the fetus and previous studies of fetal red cells isolated at the time of delivery suggest that fetal red cell life span increases with gestational age. The mechanisms underlying this phenomenon remain unknown. The phenomenon cannot be attributed simply to the switch from fetal to adult hemoglobin production because fetal red cell life span appeared to increase over the entire range of gestational ages (97-136 days), whereas the ovine fetus synthesizes little adult hemoglobin before 130 days gestation (1). Red cell life span did increase as red cell volume (i.e., MCV) decreased during gestation; theoretically, the larger fetal red cells may contribute to the shorter life span. Although a possibility, it can be concluded from the multivariate regression analysis in the present study that gestational age in addition to cell size contributes to the increase in erythrocyte life span with advancing gestation so other factors appear to be involved. Bard and Widness (2) recently reported that the life span of adult red cells transfused into very premature human infants (26.8 ± 1.5 wk gestation at birth) averaged 56.4 ± 7.0 (SD) days. This raises the interesting possibility that there may be something unique about the architecture and/or function of the fetal circulation that shortens the life span of circulating red cells. For example, cardiac output in the fetus per unit weight is much higher than in the adult (18), and this high flow may be associated with a shortened life span. However, the study by Bard and Widness should be interpreted cautiously because life span of the transfused cells was assumed to equal the time after the last transfusion when the ratio of fetal (HbF) to total hemoglobin concentration reached a maximum. In theory, transfused cell life is not the time of the maximum but rather it is the time at which the subsequent downward slope of the HbF vs. time curve reaches its autologous level. This difference would lead to an underestimation of the life span of the transfused cells.
The conclusions from the present study regarding fetal red cell life span are dependent on a number of other assumptions. First, the [14C]cyanate had no effect on life span. This is likely as the use of the [14C]cyanate label in the adult produces the same life span as determined with other labels and other methodologies (14, 16). Second, catheterization of the fetus may have in itself led to a shortened red cell life span due to factors such as an allergic reaction to the catheter material or a thrombotic response to the catheter. Although possible, these are unlikely in that we know of no support for the ideas in the thousands of papers that have been published using this animal model. Furthermore, both the immune and thrombotic systems of the fetus are immature and lack the responsiveness of the adult.
One inconsistency in our analysis merits discussion. For the parameter red cell life span change with gestational age, computer modeling with parameter optimization yielded an average value of 0.52 ± 0.22 days/day for the 12 fetuses. However, regression analysis of life span as a function of gestational age yielded a slope of 1.54 ± 0.30 days/day. We currently do not have an explanation for this apparent conflict. Notwithstanding, both analyses suggest that the life span of newly released red cells increases by ~1 day/day of gestation over the last third of gestation in the ovine fetus.
In summary, the present study suggests that red cell life span in the ovine fetus over the last third of gestation increases at a rate of ~1 day/day gestation and reaches adult values at term. Furthermore, we conclude that labeled red cell disappearance curves in the growing organism can be interpreted properly only if the expansion of blood volume with growth and potential changes in red cell life span with age are taken into account.
Perspectives
It has been widely accepted that the life span of red cells within the fetus is less than adult values even though red cell life span in the fetal circulation has not been previously reported. Although this conclusion appears to be correct, it was based largely on an inappropriate interpretation of data. That is, neither the expansion of blood volume with growth nor the skewed distribution of life spans within the circulation nor the increase in life span with gestational age were taken into account in most studies. The present study shows that these errors led to a substantial underestimation of the true life span. In fact, the error is so large that the true life span of "fetal" red cells isolated at the time of birth may be little different from adult values. Furthermore, there has been no previous explanation for the few studies that found the life span of fetal red cells to be the same as adult values. The latter studies may be accurate in that they were performed in the newborn with correction for growth, and the methodology (tracer incorporation) used determined the life span of newly produced cells. The present study suggests not only that the life span of newly produced fetal erythrocytes is longer than the mean life span, but also that the newly produced cells at term have the same life span as the adult. More importantly, the present study provides a methodology for studying erythrocyte life span in any growing organism when using the random labeling method.| |
ACKNOWLEDGEMENTS |
|---|
The technical assistance of Rachel Howe and Jesse Trujillo is sincerely appreciated.
| |
FOOTNOTES |
|---|
This study was supported in part by National Institutes of Health Grants HD-33499 and HD-20295 from the National Institute of Child Health and Human Development. Dr. Song was supported in part by Research Fund CURIMS-96-0078 of Chonnam University Research Institute of Medical Sciences, Kwangju, Korea.
Address for reprint requests and other correspondence: R. A. Brace, Dept. of Reproductive Medicine, Univ. of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0802.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 26 August 1999; accepted in final form 16 May 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Bard, H,
Battaglia FC,
Makowski EL,
and
Meschia G.
The synthesis of fetal and adult hemoglobin in sheep during the perinatal period.
Proc Soc Exp Biol Med
139:
1148-1150,
1972[Medline].
2.
Bard, H,
and
Widness JA.
The life span of erythrocytes transfused to preterm infants.
Pediatr Res
42:
9-11,
1997[ISI][Medline].
3.
Brace, RA.
Blood volume and its measurement in the chronically catheterized sheep fetus.
Am J Physiol Heart Circ Physiol
244:
H487-H494,
1983.
4.
Brace, RA.
Thoracic duct lymph flow and its measurement in the chronically catheterized sheep fetus.
Am J Physiol Heart Circ Physiol
256:
H16-H20,
1989
5.
Brace, RA.
Regulation of blood volume in utero.
In: Fetus and Neonate: Physiology and Clinical Applications, edited by Hanson MA,
Spencer JAD,
and Rodeck CH.. Cambridge, UK: Cambridge Univ. Press, 1993, vol. 1, p. 75-99.
6.
Bratteby, LE,
Garby L,
Groth T,
Schneider W,
and
Wadman B.
Studies on erythro-kinetics in infancy. XIII. The mean life span and the life span frequency function of red blood cells formed during foetal life.
Acta Paediatr Scand
57:
311-320,
1968[ISI][Medline].
7.
Dacie, JV,
and
Mollison PL.
Survival of normal erythrocytes after transfusion to patients with familial hæmoltyic anæmia.
Lancet
1:
550-552,
1943.
8.
Dancis, J,
Danoff S,
Zabriskie J,
and
Balis ME.
Hemoglobin metabolism in the premature infant.
J Pediatr
54:
748-755,
1959.
9.
Foconi, S,
and
Sjölin S.
Survival of Cr51-labeled red cells from newborn infants.
Acta Paediatr
48:
18-23,
1959.
10.
Hollingsworth, JW.
Life span of fetal erythrocytes.
J Lab Clin Med
45:
469-473,
1955.
11.
Kaplan, E,
and
Hsu KS.
Determination of erythrocyte survival in newborn infants by means of Cr51-labelled erythrocytes.
Pediatrics
27:
354-361,
1961
12.
Landaw, SA.
The use of 14C-cyanate for red blood cell survival studies.
Proc Soc Exp Biol Med
142:
712-715,
1973[Medline].
13.
Landaw, SA.
Homeostasis, survival, and red cell kinetics: measurement and imaging of red cell production.
In: Hematology: Basic Principles and Practice, edited by Hoffman R,
Benz Jr EJ,
Shattil SJ,
Furie B,
Cohen HJ,
Silberstein LE,
and McGlave P.. New York: Churchill Livingstone, 1995.
14.
Mock, DM,
Lankford GL,
Burmeister LF,
and
Strauss RG.
Circulating red cell volume and red cell survival can be accurately determined in sheep using the [14C]cyanate label.
Pediatr Res
41B:
916-921,
1997[ISI][Medline].
15.
Mock, DM,
Lankford GL,
Widness JA,
Burmeister LF,
Kahn D,
and
Strauss RG.
Measurement of red cell survival using biotin-labeled red cells: validation against 51Cr-labeled red cells.
Transfusion
3:
156-162,
1999.
16.
Mock, DM,
Strauss RG,
and
Lankford GL.
[14C]cyanate labeling of sheep red cells: covalent binding to hemoglobin continues in vivo for a day.
Pediatr Res
41A:
424-429,
1997[ISI][Medline].
17.
Pearson, HA.
Life-span of the fetal red blood cell.
J Pediatr
70:
166-171,
1967[ISI][Medline].
18.
Rudolph, AM,
and
Heymann MA.
The circulation of the fetus in utero: methods for studying distribution of blood flow, cardiac output and organ blood flow.
Circ Res
21:
163-184,
1967
19.
Shields, LE,
Widness JA,
and
Brace RA.
The hematologic and plasma iron responses to severe fetal hemorrhage in the ovine fetus.
Am J Obstet Gynecol
174:
55-61,
1996[ISI][Medline].
20.
Tucker, EM.
Red cell life span in young and adult sheep.
Res Vet Sci
4:
11-23,
1963.
21.
Wintour, EM,
Clemons G,
Butkus A,
Horvath A,
Moritz K,
and
Towstless MK.
Immunoreactive erythropoietin concentration and haemoglobin type in the perinatal period in sheep of various haemoglobin genotypes.
J Dev Physiol
14:
259-265,
1990[ISI][Medline].
This article has been cited by other articles:
![]() |
A. Montel-Hagen, L. Blanc, M. Boyer-Clavel, C. Jacquet, M. Vidal, M. Sitbon, and N. Taylor The Glut1 and Glut4 glucose transporters are differentially expressed during perinatal and postnatal erythropoiesis Blood, December 1, 2008; 112(12): 4729 - 4738. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. H. M. van den Wijngaard, B. E. Westerhof, M. G. Ross, and M. J. C. van Gemert A mathematical model of twin-twin transfusion syndrome with pulsatile arterial circulations Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1519 - R1531. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. H. M. van den Wijngaard, A. Umur, R. T. Krediet, M. G. Ross, and M. J. C. van Gemert Modeling a hydropic recipient twin in twin-twin transfusion syndrome Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2005; 288(4): R799 - R814. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Granger Maternal and fetal adaptations during pregnancy: lessons in regulatory and integrative physiology Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2002; 283(6): R1289 - R1292. [Full Text] [PDF] |
||||
![]() |
B. D. Sohl, C. Y. Cheung, J. A. Widness, and R. A. Brace Erythropoietin responses to progressive blood loss over 10 days in the ovine fetus Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2001; 281(4): R1051 - R1058. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |